TY - CHAP
T1 - Neurotransmitter Function
T2 - Presynaptic Neurotransmission: Alterations in Exocytotic/Secretory Machinery in Kindling
AU - Whiteheart, S. W.
AU - Matveeva, E. A.
AU - Vanaman, T. C.
AU - Slevin, J. T.
PY - 2009/1/1
Y1 - 2009/1/1
N2 - In molecular terms, epilepsy is a dysfunction in neurotransmission, involving either an inappropriate response to, or an altered release of, neurotransmitters (NT). We have examined the synaptosomal proteins involved in NT release to determine if alterations in their interactions correlate with epilepsy. We have quantified secretion machinery elements (SNARE - soluble . N-ethylmaleimide sensitive factor attachment protein receptors) complex and SNARE effectors) in hippocampi from electrically kindled animals. In these animals, there is a persistent, asymmetric accumulation of SNARE complexes in the hippocampus ipsilateral to the stimulating electrode, regardless of stimulation site. Treatment with levetiracetam (an antiepileptic drug which specifically binds SV2 (synaptic vesicle protein 2)) dampened this accumulation and delayed kindling. Of the SNARE effectors examined, only SV2, tomosyn, and NSF (. N-ethylmaleimide sensitive factor) showed alterations upon kindling. The implications of these findings toward an understanding of epilepsy are discussed.
AB - In molecular terms, epilepsy is a dysfunction in neurotransmission, involving either an inappropriate response to, or an altered release of, neurotransmitters (NT). We have examined the synaptosomal proteins involved in NT release to determine if alterations in their interactions correlate with epilepsy. We have quantified secretion machinery elements (SNARE - soluble . N-ethylmaleimide sensitive factor attachment protein receptors) complex and SNARE effectors) in hippocampi from electrically kindled animals. In these animals, there is a persistent, asymmetric accumulation of SNARE complexes in the hippocampus ipsilateral to the stimulating electrode, regardless of stimulation site. Treatment with levetiracetam (an antiepileptic drug which specifically binds SV2 (synaptic vesicle protein 2)) dampened this accumulation and delayed kindling. Of the SNARE effectors examined, only SV2, tomosyn, and NSF (. N-ethylmaleimide sensitive factor) showed alterations upon kindling. The implications of these findings toward an understanding of epilepsy are discussed.
KW - Epilepsy
KW - Exocytosis
KW - Kindling
KW - Neurotransmitter
KW - NSF
KW - SNAREs
UR - http://www.scopus.com/inward/record.url?scp=85069290998&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85069290998&partnerID=8YFLogxK
U2 - 10.1016/B978-012373961-2.00360-X
DO - 10.1016/B978-012373961-2.00360-X
M3 - Chapter
AN - SCOPUS:85069290998
SN - 9780123739612
SP - 892
EP - 897
BT - Encyclopedia of Basic Epilepsy Research
ER -